To date, no clinical trial has specifically evaluated BPC-157s potential to promote tumors or metastasis
Why Choose AHK-Cu
If the underlying physiology creates a persistent tendency toward weight gain, ongoing pharmaceutical support may be the most effective strategy, just as ongoing antihypertensive therapy is the most effective strategy for people with essential hypertension
Since BPC-157 promotes overall tissue repair, once the effects are noticed, they will typically stay in place, with most patients noticing long-term healing effects for months to come
In severe cases, we may consider using the intravenous medication pegloticase (Krystexxa), since it lowers the urate level the most dramatically, and can lead to the fastest shrinkage of the tophus
BPC157 vs TB500 This healing peptide that is somewhat similar to TB-500